| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |